首页 › 期刊 › 医学 › Nuclear Medicine Communications
Nuclear Medicine Communications
出版商:Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins · ISSN:0143-3636, 1473-5628 · 国家/地区:GB · 类型:journal · 官网:https://journals.lww.com/nuclearmedicinecomm/pages/default.a...
研究主题:Medical Imaging Techniques and Applications · Radiopharmaceutical Chemistry and Applications · Cardiac Imaging and Diagnostics · Medical Imaging and Pathology Studies · Radiomics and Machine Learning in Medical Imaging
数据覆盖:9 个公开学术数据源交叉核验(crossref、fqb、jcr、openalex、scimago、wikidata、xr、cwts、jufo)。
数据来源与实体核验
期刊官网 · OpenAlex 期刊实体 · Wikidata 期刊实体
核心指标
- 影响因子(JCR 2025):1.400
- JCR 分区:Q3(RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING)
- 中科院分区(2025):医学 4区,大类排名 3953/5603;小类:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学 4区,排名 151/206
- 新锐分区(2026):医学 4区
- SJR:0.399(Q3),2025 年,United Kingdom
- CWTS 2025:SNIP 0.540 · IPP 1.435 · 自引率 5.4%
- JUFO 出版渠道等级:芬兰 1 · 挪威 1 · 丹麦 1
- h-index:94
- i10 指数:2729
- 近两年篇均被引:1.09
- 载文量 11553 · 总被引 94420
- Crossref DOI 总量:11536,近期 419
逐年趋势
- 近年影响因子:2021 1.7 → 2022 1.5 → 2023 1.3 → 2024 1.3 → 2025 1.4
- 近年 SJR:2021 0.394(Q3) → 2022 0.384(Q3) → 2023 0.374(Q3) → 2024 0.393(Q3) → 2025 0.399(Q3)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- MMWR Surveillance Summaries — IF 96.9 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《Nuclear Medicine Communications》的影响因子是多少?
根据 JCR 2025 年数据,《Nuclear Medicine Communications》的最新影响因子(IF)为 1.400。
《Nuclear Medicine Communications》是几区期刊?
《Nuclear Medicine Communications》中科院分区(2025年版)为医学4区,JCR 分区为 Q3。
本刊近期代表论文
- Evaluation of physiological bone metabolic activity in the spine with 18F-fluorodeoxyglucose and 18F-sodium fluoride PET: associations with degenerative risk factors (2026 · 被引 2)
- Relationship between prostatic fluorodeoxyglucose uptake, prostatic calcifications, and urologic symptom questionnaires (2026)
- Predicting persistent/recurrent cervical lymph node metastasis in papillary thyroid carcinoma with PET/CT-based multimodal radiomics: an image-pathology matching study (2026)
- Network topology and metabolic alterations in early- and mid-stage Parkinson’s disease: insights from fluorodeoxyglucose PET imaging (2025 · 被引 6)
- Progression of intracardiac metastases from gastroenteropancreatic neuroendocrine tumors (2025 · 被引 1)
- Role of 18F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus (2023 · 被引 13)